5
5
5
Drug Origin Transparency Act of 2026
4/30/2026, 6:17 PM
Summary of Bill HR 8339
The bill titled "To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes" was introduced in the 119th Congress as H.R. 8339 on April 16, 2026. The bill's main focus is on improving drug manufacturing amount information reporting under the Federal Food, Drug, and Cosmetic Act, with additional provisions aimed at achieving other goals specified within the bill's text.
Read the Full Bill
Current Status of Bill HR 8339
Bill HR 8339 is currently in the status of Bill Introduced since April 16, 2026. Bill HR 8339 was introduced during Congress 119 and was introduced to the House on April 16, 2026. Bill HR 8339's most recent activity was Referred to the House Committee on Energy and Commerce. as of April 16, 2026
Bipartisan Support of Bill HR 8339
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
3Democrat Cosponsors
1Republican Cosponsors
2Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 8339
Primary Policy Focus
HealthAlternate Title(s) of Bill HR 8339
To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes.
To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes.
Comments

Salma Ross
911
1 month ago
I fully support the United States HR Bill 8339 to enhance drug manufacturing amount information reporting. This bill is crucial in ensuring the safety and effectiveness of medications for all Americans. By requiring manufacturers to report accurate information on drug production, we can better monitor and regulate the pharmaceutical industry. As a 61 year old woman, I believe this bill will directly impact my health and well-being by providing me with more transparency and confidence in the medications I take. It is important to prioritize the safety of consumers, and this bill is a step in the right direction. #HRBill8339 #DrugSafety #HealthcareReform
Sponsors and Cosponsors of HR 8339
Latest Bills
Physician Education for Fistula Treatment Act
Bill HR 9015June 3, 2026
POWER Act
Bill HR 9019June 3, 2026
Restore Florida Water Independence Act of 2026
Bill HR 9017June 3, 2026
Fostering TRUST Act of 2026
Bill HR 9018June 3, 2026
No U.S. Funding for UNIFIL Act
Bill HR 9020June 3, 2026
Affordable Housing and Area Median Income Fairness Act of 2026
Bill HR 9014June 3, 2026
SLUSH FUND Act of 2026
Bill HR 8910June 3, 2026
Campaign Funds Integrity Act of 2026
Bill HR 8912June 3, 2026
AVERT Future Violence Act of 2026
Bill HR 8911June 3, 2026
Prevent Government Shutdowns Act of 2026
Bill S 4632June 3, 2026



